Kim SG. Evaluation of the management of malignant ventricular tachyarrhythmias: The roles of drug therapy and implantable defibrillators. Am Heart J130:1144, 1995
2.
Graboys TB, Lown B, Podrid PJ, Silva R. Longterm survival with ventricular arrhythmias treated with antiarrhythmic drugs. Am J Cardiol50:437, 1982
3.
Mason JW, Winkle RA. Accuracy of ventricular tachycardia induction study for predicting long-term efficacy and inefficacy of antiarrhythmic drugs. N Engl J Med303:1073, 1980
4.
Singh BN. Choice and chance in drug therapy of cardiac arrhythmias: Technique versus drug-specific responses in evaluation of efficacy. Am J Cardiol72:114F, 1993
5.
The Cardiac Arrhythmia Suppression Trial (CAST) Investigators Preliminary Report. Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med321:406, 1989
6.
Cardiac Arrhythmia Suppression Trial II Investigators. Ethmozine exerts an adverse effect on mortality in survivors of acute myocardial infarction. N Engl J Med327:227, 1992
7.
Mason JW (on Behalf of the ESVEM Investigators). A randomized comparison of electrophysiologic study to electrocardiographic monitoring for prediction of antiarrhythmic drug efficacy in patients with ventricular tachyarrhythmias. N Engl J Med329:445, 1993
8.
Mason JW (on Behalf of the ESVEM Investigators). A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. N Engl J Med329:445, 1993
9.
Singh BN. Whither antiarrhythmic drugs? In Singh BN, Wellens HJJ, Hiraoka M (eds). Electropharmacological Control of Cardiac Arrhythmias. To Delay Conduction or to Prolong Refractoriness?Future Publishing Company, Mt. Kisco, New York, pp. 713-731, 1994
10.
Steinbeck G, Andersen D, Bach P, Haberi R, Oeff M, Hoffman E, Von Leitner ER. A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blacker therapy to patients with symptomatic sustained tachyarrhythmias. N Engl J Med327:987, 1992
11.
Kuhlkamp V, Mermi J, Mewis C, Braun U, Seipcl L. Does programmed electrical stimulation predict long-term efficacy of dl-sotalol?Circulation90:1, 1994
12.
Kehoe RF, McNeil DJ, Zhenthlin TA, et al. Safety and efficacy of oral sotalol for sustained ventricular tachyarrhythmias refractory to other antiarrhythmic agents. Am J Cardiol175:56A, 1993
13.
Salerno D, Gillingam KJ, Berry DA, Hodges M. A comparison of antiarrhythmic drugs for the suppression of ventricular ectopic depolarization: A meta-analysis. Am Heart J120:340, 1990
14.
Weinberg BA, Miles WM, Klein LS, et al. Five year follow-up of 589 patients treated with amiodarone. Am Heart J125:109, 1993
15.
The CASCADE Investigators.The Cascade Study: Randomized anti-arrhythmic drug therapy in survivors of cardiac arrest in Seattle. Am J Cardiol72:280, 1993
16.
Singh BN. Implantable cardioverter defibrillators: Not the ultimate gold standard for gauging therapy of VT/fibrillation?Am J Cardiol73:1211, 1994
17.
Zips DP. Implantable cardioverter-defibrillator. Life saver or a device looking for a disease?Circulation91:2115, 1995
18.
Greenspan AJ, Volosin KJ, Greenberg RM, Jefferies L, Rotmensch HH. Amiodarone therapy: Role of early and late electrophysiologic studies. J Am Coll Cardial11:117, 1988
19.
Nasir N, Swarm US, Baohene KA, Doyle TK, Pacifico A. Therapy of sustained ventricular arrhythmias with amiodarone: Prediction of efficacy with serial electrophysiologic studies. J Cardiovasc Pharmacol Therapeut1:123, 1996
20.
Singh SN, Gross-Fisher S, Fletcher RD, Singh BN, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmias. N Engl J Med333:77, 1995
21.
Kim SG. Implantable defibrillator therapy: Does it really prolong life? How can we prove it?Am J Cardiol71:1213, 1993
